Publications for Sten Thorstenson
Co-author map based on ISI articles 2007-

Keywords

tumours tumour treatment tamoxifen survival risk recurrence receptor prognostic patients npi nottingham node markers male grade death cancer breast atm

Journal Articles

Sten Thorstenson, Jesper Molin and Claes Lundström
  Implementation of large‑scale routine diagnostics using whole slideimaging in Sweden: Digital pathology experiences 2006-2013
  Journal of Pathology Informatics, 2014, 5(14), .

Cecilia Nilsson, Anthoula Koliadi, Ida Johansson, Cecilia Ahlin, Sten Thorstenson, Leif Bergkvist, Ingrid Hedenfalk and Marie-Louise Fjallskog
  High proliferation is associated with inferior Outcome in male breast cancer patients
  Modern Pathology, 2013, 26(1), 87-94.
 Web of Science® Times Cited: 3

Cecilia Nilsson, Ida Johansson, Cecilia Ahlin, Sten Thorstenson, Rose-Marie Amini, Marit Holmqvist, Leif Bergkvist, Ingrid Hedenfalk and Marie-Louise Fjallskog
  Molecular subtyping of male breast cancer using alternative definitions and its prognostic impact
  Acta Oncologica, 2013, 52(1), 102-109.
 Web of Science® Times Cited: 3

L Arlehag, Gunnar Adell, Annica Knutsen Holmqvist, Sten Thorstenson and Xiao-Feng Sun
  ATM expression in rectal cancers with or without preoperative radiotherapy
  Oncology Reports, 2005, 14(2), 313-317.
 Web of Science® Times Cited: 4

L Ryden, K Jirstrom, PA Bendahl, M Ferno, Bo Nordenskjöld, Olle Stål, Sten Thorstenson, PE Jonsson and G Landberg
  Tumor-specific expression of vascular endothelial growth factor receptor 2 but not vascular endothelial growth factor or human epidermal growth factor receptor 2 is associated with impaired response to adjuvant tamoxifen in premenopausal breast cancer
  Journal of Clinical Oncology, 2005, 23(21), 4695-4704.
 Web of Science® Times Cited: 53

Lisa Rydén, Per-Ebbe Jönsson, Gunilla Chebil, Monika Dufmats, Mårten Fernö, Karin Jirström, Ann-Christine Källström, Göran Landberg, Olle Stål, Sten Thorstenson and Bo Nordenskjöld
  Two years of adjuvant tamoxifen in premenopausal patients with breast cancer: a randomised, controlled trial with long-term follow-up
  European Journal of Cancer, 2005, 41(2), 256-264.
 Web of Science® Times Cited: 55

Amir Reza Razavi, Hans Gill, Olle Stål, Marie Sundquist, Sten Thorstenson, Hans Åhlfeldt, Nosrat Shahsavar and The South-East Swedish Breast Cancer Study Group
  Exploring cancer register data to find risk factors for recurrence of breast cancer: Application of Canonical Correlation Analysis
  BMC Medical Informatics and Decision Making, 2005, 5(29), 29-35.
   Fulltext  PDF  

Marie Sundquist, Sten Thorstenson, Lars Brudin, Sten Wingren and Bo Nordenskjöld
  Incidence and prognosis in early onset breast cancer
  Breast, 2002, 11(1), 30-35.
 Web of Science® Times Cited: 19

Massimiliano Gentile, Åsa Wiman, Sten Thorstenson, Niklas Loman, Åke Borg and Sten Wingren
  Deletion mapping of chromosome segment 11q24-q25, exhibiting extensive allelic loss in early onset breast cancer
  International Journal of Cancer, 2001, 92(2), 208-213.
 Web of Science® Times Cited: 19

Marie Sundquist, Sten Thorstenson, Lars Brudin, Olle Stål and Bo Nordenskjöld
  A comparison between flow cytometric assessment of S-phase fraction and Nottingham histologic grade as prognostic instruments in breast cancer
  Breast Cancer Research and Treatment, 2000, 63(1), 11-15.
 Web of Science® Times Cited: 5

Marie Sundquist, Sten Thorstenson, Claes Klintenberg, Lars Brudin and Bo Nordenskjöld
  Indicators of loco-regional recurrence in breast cancer
  European Journal of Surgical Oncology, 2000, 26(4), 357-362.
 Web of Science® Times Cited: 14

Marie Sundquist, Sten Thorstenson, Lars Brudin and Bo Nordenskjöld
  Applying the Nottingham Prognostic Index to a Swedish breast cancer population
  Breast Cancer Research and Treatment, 1999, 53(1), 1-8.